3 Factor Indexing’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$66 Hold
1
– – ﹤0.01% 412
2026
Q2
$75 Hold
1
– – ﹤0.01% 419
2026
Q1
$75 Buy
+1
New +$72 ﹤0.01% 433

Other funds holding BBIO

3 Factor Indexing's BBIO Position: Q3 2026 in Review

3 Factor Indexing held its BridgeBio Pharma (BBIO) position steady in Q3 2026 at 1 share worth $66. The position accounts for ﹤0.01% of the portfolio, ranked #412.

3 Factor Indexing first reported a position in BBIO in Q1 2026 and has held it in 3 quarters since. The position peaked at $75 in Q2 2026. 470 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • 3 Factor Indexing held 1 share of BridgeBio Pharma worth $66 as of Q3 2026.
  • 3 Factor Indexing left its BridgeBio Pharma share count unchanged in Q3 2026.
  • BridgeBio Pharma made up ﹤0.01% of 3 Factor Indexing's portfolio in Q3 2026, its #412 holding.
  • 3 Factor Indexing first reported a position in BridgeBio Pharma in Q1 2026 and has held it in 3 quarters since.
  • 3 Factor Indexing's BridgeBio Pharma position peaked at $75 in Q2 2026.
  • 470 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on 3 Factor Indexing's 13F filing for Q3 2026, filed 15 Oct 2026.